TWD 695.0
(-3.34%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.99 Billion TWD | 140.02% |
2022 | 2.91 Billion TWD | 74.23% |
2021 | 1.67 Billion TWD | 137.51% |
2020 | 703.88 Million TWD | 9.46% |
2019 | 643.03 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.95 Billion TWD | 29.56% |
2024 Q1 | 1.5 Billion TWD | -11.25% |
2023 Q2 | 1.72 Billion TWD | -10.45% |
2023 Q4 | 1.69 Billion TWD | 3.2% |
2023 FY | 6.99 Billion TWD | 140.02% |
2023 Q1 | 1.92 Billion TWD | 76.15% |
2023 Q3 | 1.64 Billion TWD | -4.66% |
2022 Q3 | 901.98 Million TWD | 0.0% |
2022 FY | 2.91 Billion TWD | 74.23% |
2022 Q4 | 1.09 Billion TWD | 21.2% |
2021 FY | 1.67 Billion TWD | 137.51% |
2020 FY | 703.88 Million TWD | 9.46% |
2019 FY | 643.03 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Grape King Bio Ltd | 8.53 Billion TWD | 18.073% |
Standard Chem & Pharm CO., LTD. | 2.72 Billion TWD | -156.524% |
Maywufa Company Ltd. | 854.37 Million TWD | -718.29% |
ScinoPharm Taiwan, Ltd. | 1.21 Billion TWD | -474.943% |
Lotus Pharmaceutical Co., Ltd. | 8.33 Billion TWD | 16.163% |
LIWANLI Innovation Co., Ltd. | 15.08 Million TWD | -46251.774% |
YungShin Global Holding Corporation | 2.91 Billion TWD | -140.161% |
PhytoHealth Corporation | 67.64 Million TWD | -10235.494% |
SCI Pharmtech, Inc. | 350.32 Million TWD | -1895.655% |
Formosa Laboratories, Inc. | 1.9 Billion TWD | -267.327% |
PharmaEssentia Corporation | 4.49 Billion TWD | -55.531% |